<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01162928</url>
  </required_header>
  <id_info>
    <org_study_id>HC-G-H-0804</org_study_id>
    <nct_id>NCT01162928</nct_id>
    <nct_alias>NCT01148589</nct_alias>
  </id_info>
  <brief_title>Parenteral Nutrition With Intravenous and Oral Fish Oil for Intensive Care Patients</brief_title>
  <official_title>Assessment of the Benefit From Combined Administration of Oral and Intravenous Nutrition - Enriched With Omega-3 Fatty Acids - for Intensive Care Patient</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>B. Braun Melsungen AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>B. Braun Melsungen AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to assess the effect of fish oil-enriched enteral and parenteral
      nutrition on blood oxygenation in critically ill patients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">November 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in blood oxygenation (PaO2/FIO2 ratio)</measure>
    <time_frame>day 1 to day 6</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate of parenteral nutrition associated complications equal or better compared to current practice</measure>
    <time_frame>day 1 to day 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>disease related complications</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>28 day-mortality</measure>
    <time_frame>Day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes in fatty acid composition of cell membranes</measure>
    <time_frame>Day 12</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3-chamber-bag combined with Oxepa</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3-chamber-bag combined with Pulmocare</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nutriflex Omega special + Oxepa</intervention_name>
    <description>3-chamber-bag combined with enteral nutrition</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nutriflex Lipid special + Pulmocare</intervention_name>
    <description>3-chamber-bag combined with enteral nutrition</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion: - signed informed consent

          -  mechanically-ventilated adults (age 18-80) admitted to Intensive Care Unit,

          -  enteral nutrition does not meet the nutrition goal (at least 80 % of the resting
             energy expenditure) within the past 36 hours

          -  APACHE II score above the median value of the intensive care unit (id est &gt; 20)

        Exclusion: - do not resuscitate status

          -  cardiogenic pulmonary edema

          -  previous (&lt; 1 month) or ongoing need for corticosteroids &gt; 0.1 mg/kg prednisolon-
             equi-valent or other immune suppressive treatment

          -  serum triglycerides &gt; 300 mg/dl at screening

          -  alterations of coagulation (platelets &lt;100.000 mm3), PTT &gt; 60 sec, INR ≥ 2.5 without
             therapeutic intervention

          -  pregnancy

          -  participation in a clinical study with an investigational drug within one month prior
             to the start of this clinical trial

          -  known or suspected drug abuse

          -  general contraindications for infusion therapy such as acute pulmonary oedema,
             hyper-hydration and decompensated cardiac insufficiency

          -  known hypersensitivity to egg-, soy-, and fish proteins or any of the ingredients

          -  autoimmune disease or HIV

          -  uncompensated hemodynamical failure of any origin (hemorrhagic shock, myocardial
             infarction, cardiac failure)

          -  uncompensated ketoacidosis caused by Diabetes mellitus within 7 days prior to onset of
             study

          -  uncompensated renal insufficiency with serum creatinine &gt; 1.5 mg/dL (&gt; 133 µmol/L)

          -  patients with severe liver dysfunction with bilirubin &gt; 2.5 mg/dL (&gt; 43 µmol/L)

          -  necrotizing pancreatitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre Singer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rabin Medical Center, Beilinson Campus</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rabin Medical Center, Beilinson Campus</name>
      <address>
        <city>Petah-Tikva</city>
        <zip>49100</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 14, 2010</study_first_submitted>
  <study_first_submitted_qc>July 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 15, 2010</study_first_posted>
  <last_update_submitted>April 26, 2018</last_update_submitted>
  <last_update_submitted_qc>April 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>critically ill, mechanically ventilated patients requiring enteral and parenteral nutritional support</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

